UnitedHealth Group Incorporated (NYSE:UNH) on Tuesday posted upbeat third-quarter results.

UnitedHealth Group reported quarterly earnings of $4.69 per share which beat the analyst consensus estimate of $4.15 per share. The company reported quarterly sales of $112.694 billion which beat the analyst consensus estimate of $111.403 billion.

UnitedHealth raised its full-year 2026 adjusted earnings guidance to at least $20.50 per share from its previous range of $19.50 to $20. The revised outlook exceeds the analyst consensus estimate of $19.86.

The company also increased its GAAP earnings forecast to at least $19.50 per share, up from its previous guidance of $18.45 to $18.95. Analysts had expected $18.35 per share.

“Our third quarter results reflect the discipline and execution our teams are bringing to every part of our business, as we continue evolving UnitedHealth Group to deliver a simpler, more supportive experience for patients and the clinicians who care for them,” said Stephen Hemsley, chief executive officer of UnitedHealth Group.

UnitedHealth shares gained 3% to trade at $389.04 on Wednesday.

These analysts made changes to their price targets on UnitedHealth following earnings announcement.

• Baird analyst Michael Ha maintained the stock with a Neutral and lowered the price target from $453 to $427.
• Barclays analyst Andrew Mok maintained the stock with an Overweight rating and cut the price target from $441 to $440.

Considering buying UNH stock? Here’s what analysts think:

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.